Pfizer Ltd.
Snapshot View

3504.95 +61.60 ▲1.8%

29 March 2023, 04:01:00 PM
Volume: 1,514

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pfizerltd.co.in
Market Cap 16,040.07 Cr.
Enterprise Value(EV) 14,479.83 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 135.54 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 25.87 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 670.39 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.23 Calculated using Price: 3,506.20
Dividend Yield 1.00 Period Ending 2022-03
No. of Shares Subscribed 4.57 Cr. 45,747,732 Shares
FaceValue 10
Company Profile
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.79%
1 Week
-0.74%
1 Month
-7.64%
3 Month
-22.04%
6 Month
-17.27%
1 Year
-20.60%
2 Year
-19.75%
5 Year
+60.38%
10 Year
+230.62%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.77 5.31 14.75 14.70 14.11 15.07 15.89 17.19 23.30
Return on Capital Employed (%) 28.96 15.87 22.78 22.62 21.49 23.22 20.38 23.62 29.78
Return on Assets (%) 14.91 4.00 11.22 10.95 10.36 11.25 12.20 13.00 17.24

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 658 1,973 2,164 2,419 2,683 3,011 3,395 2,393 2,864 2,916
Non Curr. Liab. -19 -35 66 62 52 37 136 85 136 85
Curr. Liab. 303 609 658 780 954 892 873 774 853 764
Minority Int.
Equity & Liab. 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,765
Non Curr. Assets 257 1,295 1,256 1,210 1,273 1,225 1,357 1,344 1,457 1,420
Curr. Assets 686 1,252 1,632 2,051 2,417 2,715 3,048 1,908 2,396 2,345
Misc. Exp. not W/O
Total Assets 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,765

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,112 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,402
Other Income 109 72 87 101 114 167 184 81 63 87
Total Income 1,221 1,925 2,099 2,067 2,083 2,249 2,336 2,320 2,674 2,489
Total Expenditure -873 -1,474 -1,579 -1,616 -1,468 -1,516 -1,579 -1,526 -1,775 -1,609
PBIDT 349 451 520 451 615 733 757 794 899 879
Interest -1 -2 -1 -2 -1 -2 -11 -15 -11 -15
Depreciation -8 -131 -58 -63 -66 -71 -103 -109 -115 -113
Taxation -119 -138 -165 -180 -188 -231 -133 -171 -160 -184
Exceptional Items -111 10 130 53
PAT 221 70 305 337 360 429 509 498 613 620
Adjusted EPS 74 15 67 74 79 94 111 109 134 136

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -16 132 113 345 329 332 98 323 427 667
Cash Fr. Inv. 626 103 -89 -701 -250 -238 35 1,530 -469 -575
Cash Fr. Finan. -43 -1,360 -1 -62 -83 -110 -110 -164 -1,571 -181
Net Change 567 -1,125 23 -417 -3 -17 23 1,690 -1,613 -88
Cash & Cash Eqvt 1,433 308 488 71 68 51 74 1,764 151 63

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92
Public 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 28 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agent of the Company KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s)We shall issue the Letter of Confirmation(s) upon completion of necessary formalities by the shareholder(s).Please take the above on record.
Fri, 24 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agent of the Company KFin Technologies Limited has received below mentioned requests for issue of duplicate Share Certificate(s) from the Shareholder(s).We shall issue the Letter of Confirmation(s) upon completion of necessary formalities by the shareholder(s).Please take the above on record.
Fri, 24 Feb 2023
Update On Sale Of Thane Business Undertaking To Vidhi Research And Development LLP
We wish to inform you that the Company has recently received all requisite approvals from the concerned authorities and both the parties (the Company and Vidhi) have completed the conditions precedents set out in the BTA. Accordingly the Company has transferred its Business Undertaking at Thane including Land Plant & Machinery and all the workmen employed at the said Business Undertaking to Vidhi Research and Development LLP effective close of business February 24 2023.Please take the above on record.

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Pfizer Ltd.

What is Pfizer share price?

Can I buy Pfizer shares now?

What is the Dividend Yield of Pfizer?

What is the Market Cap of Pfizer?

What are the key metrics to analyse Pfizer?

What is the 52 Week High and Low of Pfizer?

What is the trend of Pfizer share price?